Connection

ALEXANDER LAZAR to Cyclin-Dependent Kinase Inhibitor p21

This is a "connection" page, showing publications ALEXANDER LAZAR has written about Cyclin-Dependent Kinase Inhibitor p21.
  1. Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma. Oncotarget. 2014 Oct 15; 5(19):9065-78.
    View in: PubMed
    Score: 0.107
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.